Collectively, the above studies based on the interrogation of CRC transcriptomes indicate that gene signatures of predictive power associated with poor CRC diagnosis and therapy resistance derive mostly from the stroma; these findings also show the importance of TGF-β signaling in determining a poor prognosis at advanced stages of the disease. The gene discussed is TGFB1; the disease is colorectal carcinoma.